Explore a selection of our essential drug information below, or:
Identification
- Summary
Bassia scoparia pollen is an extract from Bassia scoparia pollen used in allergy testing.
- Generic Name
- Bassia scoparia pollen
- DrugBank Accession Number
- DB10928
- Background
Bassia scoparia pollen is the pollen of the Bassia scoparia plant. Bassia scoparia pollen is mainly used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- burning bush pollen extract
- Kochia scoparia pollen
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Burning Bush Pollen Injection 0.05 g/1mL Cutaneous; Intradermal; Subcutaneous Allermed Laboratories, Inc. 1974-03-12 Not applicable US 
Center-AL - Kochia Scoparia Pollen Injection, suspension 10000 [PNU]/1mL Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-11 US Firebush Kochia Solution 0.1 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Firebush Kochia Solution 40000 [PNU]/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Firebush Kochia Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Central Western Weed Mix Bassia scoparia pollen (6666.6666 [PNU]/1mL) + Chenopodium album pollen (6666.6666 [PNU]/1mL) + Salsola kali pollen (6666.6666 [PNU]/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Central Western Weed Mix Bassia scoparia pollen (0.0003333 g/1mL) + Chenopodium album pollen (0.0003333 g/1mL) + Salsola kali pollen (0.0003333 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Central Western Weed Mix Bassia scoparia pollen (0.016666 g/1mL) + Chenopodium album pollen (0.016666 g/1mL) + Salsola kali pollen (0.016666 g/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Number Four Weed Mixture Bassia scoparia pollen (0.0036 g/1mL) + Amaranthus retroflexus pollen (0.0036 g/1mL) + Amaranthus tuberculatus pollen (0.0036 g/1mL) + Artemisia californica pollen (0.0036 g/1mL) + Artemisia dracunculus pollen (0.0036 g/1mL) + Artemisia frigida pollen (0.0036 g/1mL) + Artemisia tridentata pollen (0.0036 g/1mL) + Artemisia vulgaris pollen (0.0036 g/1mL) + Chenopodium album pollen (0.0036 g/1mL) + Iva axillaris pollen (0.0036 g/1mL) + Rumex acetosella pollen (0.0036 g/1mL) + Rumex crispus pollen (0.0036 g/1mL) + Salsola kali pollen (0.0036 g/1mL) + Xanthium strumarium pollen (0.0036 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-03-23 Not applicable US Number Three Weed Mixture Bassia scoparia pollen (0.0125 g/1mL) + Amaranthus retroflexus pollen (0.0125 g/1mL) + Chenopodium album pollen (0.0125 g/1mL) + Rumex acetosella pollen (0.0125 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1996-07-11 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 07A108ZKW5
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/ml Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/ml Injection Cutaneous; Intradermal; Subcutaneous 0.05 g/1mL Injection, suspension Subcutaneous 10000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 20000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 40000 [PNU]/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 0.02 g/1mL Injection, solution Intradermal 1000 [PNU]/1mL Injection, solution Percutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.10 g/1mL Injection, solution Subcutaneous 20000 [PNU]/1mL Injection, solution Subcutaneous 40000 [PNU]/1mL Patch Cutaneous Injection, solution Intradermal 500 [PNU]/1mL Injection, solution Percutaneous; Subcutaneous 0.05 g/1mL Injection, solution Percutaneous; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous Injection, solution Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53